Nautilus Biotechnology NAUT
NASDAQ NAUT
$3.22 +0.62 (+23.85%)
As of: Oct 23, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) Cash & Current Investments (2020 - 2026)

Updated

Nautilus Biotechnology's Cash & Current Investments was $84.03 million in Q2 2026, down 43.2% from $147.87 million a year earlier and down 12.3% from the prior quarter.

Analysis

Nautilus Biotechnology (NAUT) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Nautilus Biotechnology came in at $103.41 million, down 20.4% from FY2024.

  • Cash & Current Investments has now declined for four consecutive years, though with a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $129.89 million in FY2024 (-25.1%), $173.42 million in FY2023 (-6.0%), $184.47 million in FY2022 (-46.6%) and $345.73 million in FY2021 (+350.5%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q1 2021.
  • Compared with a year earlier, Cash & Current Investments has declined for eight straight quarters, with an average decline of 23.1% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 350.5%); the worst was Q1 2023 (a decline of 48.4%).
  • Per Business Quant data, NAUT's Cash & Current Investments in the three quarters before Q2 2026 was $95.87 million (Q1 2026), $103.41 million (Q4 2025) and $131.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn 4.06 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn 5.60 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn 4.35 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn 4.04 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn 8.82 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn 3.48 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn 539.00 Mn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn 709.00 Mn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn 4.25 Bn
10 Nautilus Biotechnology 403.03 Mn -11.70 Mn 175,000.00 84.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.03 Mn
Mar 31, 2026 95.87 Mn
Dec 31, 2025 103.41 Mn
Sep 30, 2025 131.43 Mn
Jun 30, 2025 147.87 Mn
Mar 31, 2025 138.81 Mn
Dec 31, 2024 129.89 Mn
Sep 30, 2024 140.61 Mn
Jun 30, 2024 167.44 Mn
Mar 31, 2024 181.37 Mn
Dec 31, 2023 173.42 Mn
Sep 30, 2023 183.29 Mn
Jun 30, 2023 163.30 Mn
Mar 31, 2023 167.35 Mn
Dec 31, 2022 184.47 Mn
Sep 30, 2022 257.97 Mn
Jun 30, 2022 299.34 Mn
Mar 31, 2022 324.12 Mn
Dec 31, 2021 345.73 Mn
Sep 30, 2021 347.35 Mn
API Access

Nautilus Biotechnology Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NAUT&period=max&api_key=YOUR_API_KEY